Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor

Neuroscience

Volumn 74, Issue 2, 1996, Pages 303-311

  Heinrichs, S C ^a,d   Stenzel Poore, M P ^b   Gold, L H ^a   Battenberg, E ^a   Bloom, F E ^a   Koob, G F ^a   Vale, W W ^c   Merlo Pich, E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

chlordiazepoxide; emotionality; hippocampus; memory; stress

Indexed keywords

ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMOTIONALITY; FORCED SWIMMING TEST; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MAZE TEST; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; STRESS; TASK PERFORMANCE; TRANSGENIC MOUSE;

EID: 0030593449     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00140-6     Document Type: Article

References (46)

1. Abel E. L., Hannigan J. H. Effects of chronic forced swimming and exposure to alarm substance: physiological and behavioral consequences. Physiol. Behav. 52:1992;781-785.
2. Arolfo M. P., Brioni J. D. Diazepam impairs place learning in the Morris water maze. Behav. neural Biol. 55:1991;131-136.
3. Aubry J.-M., Bartanusz V., Driscoll P., Schulz P., Steimer T., Kiss J. Z. Corticotropin-releasing factor and vasopressin mRNA levels in Roman high- and low-avoidance rats: response to open-field exposure. Neuroendocrinology. 61:1995;89-97.
4. Bodnoff S. R., Humphreys A. G., Lehman J. C., Diamond D. M., Rose G. M., Meaney M. J. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J. Neurosci. 15:1995;61-69.
5. Cahill L., Prins B., Weber M., McGaugh J. L. β-Adrenergic activation and memory for emotional events. Nature. 371:1994;702-704.
6. Chrousos G. P., Gold P. W. The concepts of stress and stress system disorders. J. Am. med. Ass. 267:1992;1244-1252.
7. Conrad C. D., Roy E. J. Selective loss of hippocampal granule cells following adrenalectomy: implications for spatial memory. J. Neurosci. 13:1993;2582-2590.
8. Crawley J. N. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmac. Biochem. Behav. 15:1981;695-699.
9. Crawley J. N., Olschowka J. A., Diz D. I., Jacobowitz D. M. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat. Peptides. 6:1985;891-901.
10. Dachir S., Kadar T., Robinzon B., Levy A. Cognitive deficits induced in young rats by long-term corticosterone administration. Behav. neural Biol. 60:1993;103-109.
11. Davidson M., Stern R. G. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Psychiat. Clin. N. Am. 14:1991;461-482.
12. Dawson G. R., Heyes C. M., Iversen S. D. Pharmacological mechanisms and animal models of cognition. Behav. Pharmac. 3:1992;285-297.
13. Deutsch J. A. Spatial learning in mutant mice. Science. 262:1993;760-761.
14. Diamant M., De Wied D. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity. Neuroendocrinology. 57:1993;1071-1081.
15. Evenden J. L., Ryan C. N. and Mattila M. E. (1993) Behavioural testing of antidepressants: a practical pre-clinical approach to clinical problems. In Behavioural Neuroscience (ed. Sahgal A.), Vol. 1, pp. 55-91. IRL, Oxford University Press.
16. Fernández-Teruel A., Escorihuela R. M., Núñez J. F., Zapata A., Boix F., Salazar W., Tobeña A. The early acquisition of two-way (shuttle-box) avoidance as an anxiety-mediated behavior: psychopharmacological validation. Brain Res. Bull. 26:1991;173-176.
17. Forster M. J., Lal H. Within-subjects behavioral analysis of recent memory in aging mice. Behav. Pharmac. 3:1992;337-349.
18. Francis D. D., Zaharia M. D., Shanks N., Anisman H. Stress-induced disturbances in Morris water-maze performance: interstrain variability. Physiol. Behav. 58:1995;57-65.
19. Goeders N. E., De Souza E. B., Kuhar M. J. Benzodiazepine receptor GABA ratios: regional differences in rat brain and modulation by adrenalectomy. Eur. J. Pharmac. 129:1986;363-366.
20. Hamon M. Neuropharmacology of anxiety: perspectives and prospects. Trends pharmac. Sci. 15:1994;36-39.
21. Hilakivi L. A., Lister R. G. Correlations between behavior of mice in Porsolt's swim test and in tests of anxiety, locomotion, and exploration. Behav. neural Biol. 53:1990;153-159.
22. Ingram D. K. Complex maze learning in rodents as a model of age-related memory impairment. Neurobiol. Aging. 9:1988;475-485.
23. Koob G. F. (1987) Neuropeptides and memory. In Handbook of Psychopharmacology (eds Iversen L. L. and Iversen S. D.), Vol. 19, pp. 531-573. Plenum, New York.
24. Koob G. F. (1991) Arousal, stress, and inverted U-shaped curves: implications for cognitive function. In Cognitive Neuroscience (eds Weingartener H. and Lister R.), pp. 300-313. Oxford University Press.
25. Koob G. F., Cole B. J., Swerdlow N. R., Le Moal M., Britton K. T. Stress, performance, and arousal: focus on CRF. NIDA Res. Monogr. 97:1990;163-176.
26. Lee E. H. Y., Sung Y. J. Differential influences of corticotropin-releasing factor on memory retention of aversive learning and appetitive learning in rats. Behav. neural Biol. 52:1989;285-294.
27. Levy A., Dachir S., Arbel I., Kadar T. Aging, stress, and cognitive function. Ann. N. Y. Acad. Sci. 717:1994;79-88.
28. Luine V. N., Spencer R. L., McEwen B. S. Effects of chronic corticosterone ingestion on spatial memory performance and hippocampal serotonergic function. Brain Res. 616:1993;65-70.
29. Martignoni E., Costa A., Sinforiani E., Liuzzi A., Chiodini P., Mauri M., Bono G., Nappi G. The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology. 17:1992;343-354.
30. McEntee W. J., Crook T. H. Cholinergic function in the aged brain: implications for treatment of memory impairments associated with aging. Behav. Pharmac. 3:1992;327-336.
31. McGaugh J. L. Hormonal influences on memory. A. Rev. Psychol. 34:1983;297-323.
32. McGaugh J. L., Introini-Collison I. B., Nagahara A. H., Cahill L. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage. Neurosci. Biobehav. Rev. 14:1990;425-431.
33. McNamara R. K., Skelton R. W. Diazepam impairs acquisition but not performance in the Morris water maze. Pharmac. Biochem. Behav. 38:1991;651-658.
34. McNamara R. K., Skelton R. W. Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze. Pharmac. Biochem. Behav. 41:1992;529-538.
35. McNamara R. K., Skelton R. W. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 18:1993;33-49.
36. Merlo Pich E., Samanin R. A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat. Pharmac. Rev. 21:1989;595-602.
37. Mondadori C., Ducret T., Häusler A. Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics. Psychopharmacologia. 108:1992;11-15.
38. Muglia L. J., Jenkins N. A., Gilbert D. J., Copeland N. G., Majzoub J. A. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J. clin. Invest. 93:1994;2066-2072.
39. Olton D. S., Markowska A. L., Pang K., Golski S., Voytko M. L., Gorman L. K. Comparative cognition and assessment of cognitive processes in animals. Behav. Pharmac. 3:1992;307-318.
40. Sapolsky R. M. Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav. Brain Res. 57:1993;175-182.
41. Sapolsky R. M., Pulsinelli W. A. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science. 229:1985;1397-1400.
42. Stenzel-Poore M. P., Cameron V. A., Vaughan J., Sawchenko P. E., Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130:1992;3378-3386.
43. Stenzel-Poore M. P., Heinrichs S. C., Rivest S., Koob G. F., Vale W. W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14:1994;2579-2584.
44. Stewart C. A. and Morris R. G. M. (1993) The watermaze. In Behavioural Neuroscience (ed. Sahgal A.), Vol. 1, pp. 107-122. IRL, Oxford University Press.
45. Veldhuis H. D., De Wied D. Differential behavioral actions of corticotropin-releasing factor (CRF). Pharmac. Biochem. Behav. 21:1983;707-713.
46. Zhang L., Barrett J. E. Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons. Biol. Psychiat. 27:1990;953-967.